These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 17050615)

  • 1. Multiplicity of expression of FXYD proteins in mammalian cells: dynamic exchange of phospholemman and gamma-subunit in response to stress.
    Arystarkhova E; Donnet C; Muñoz-Matta A; Specht SC; Sweadner KJ
    Am J Physiol Cell Physiol; 2007 Mar; 292(3):C1179-91. PubMed ID: 17050615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of differentiation, de novo innervation, and electrical pulse stimulation on mRNA and protein expression of Na+,K+-ATPase, FXYD1, and FXYD5 in cultured human skeletal muscle cells.
    Jan V; Miš K; Nikolic N; Dolinar K; Petrič M; Bone A; Thoresen GH; Rustan AC; Marš T; Chibalin AV; Pirkmajer S
    PLoS One; 2021; 16(2):e0247377. PubMed ID: 33635930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FXYD proteins stabilize Na,K-ATPase: amplification of specific phosphatidylserine-protein interactions.
    Mishra NK; Peleg Y; Cirri E; Belogus T; Lifshitz Y; Voelker DR; Apell HJ; Garty H; Karlish SJ
    J Biol Chem; 2011 Mar; 286(11):9699-712. PubMed ID: 21228272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential cellular expression of FXYD1 (phospholemman) and FXYD2 (gamma subunit of Na, K-ATPase) in normal human tissues: a study using high density human tissue microarrays.
    Floyd RV; Wray S; Martín-Vasallo P; Mobasheri A
    Ann Anat; 2010 Feb; 192(1):7-16. PubMed ID: 19879113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural interactions between FXYD proteins and Na+,K+-ATPase: alpha/beta/FXYD subunit stoichiometry and cross-linking.
    Lindzen M; Gottschalk KE; Füzesi M; Garty H; Karlish SJ
    J Biol Chem; 2006 Mar; 281(9):5947-55. PubMed ID: 16373350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Mechanisms and Kinetic Effects of FXYD1 and Phosphomimetic Mutants on Purified Human Na,K-ATPase.
    Mishra NK; Habeck M; Kirchner C; Haviv H; Peleg Y; Eisenstein M; Apell HJ; Karlish SJ
    J Biol Chem; 2015 Nov; 290(48):28746-59. PubMed ID: 26429909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phospholemman, a single-span membrane protein, is an accessory protein of Na,K-ATPase in cerebellum and choroid plexus.
    Feschenko MS; Donnet C; Wetzel RK; Asinovski NK; Jones LR; Sweadner KJ
    J Neurosci; 2003 Mar; 23(6):2161-9. PubMed ID: 12657675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FXYD proteins: new tissue- and isoform-specific regulators of Na,K-ATPase.
    Geering K; Béguin P; Garty H; Karlish S; Füzesi M; Horisberger JD; Crambert G
    Ann N Y Acad Sci; 2003 Apr; 986():388-94. PubMed ID: 12763855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [FXYD proteins: novel regulators of Na,K-ATPase].
    Delprat B; Bibert S; Geering K
    Med Sci (Paris); 2006; 22(6-7):633-8. PubMed ID: 16828040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation of phospholemman (FXYD1) by protein kinases A and C modulates distinct Na,K-ATPase isozymes.
    Bibert S; Roy S; Schaer D; Horisberger JD; Geering K
    J Biol Chem; 2008 Jan; 283(1):476-486. PubMed ID: 17991751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FXYD1 negatively regulates Na(+)/K(+)-ATPase activity in lung alveolar epithelial cells.
    Wujak ŁA; Blume A; Baloğlu E; Wygrecka M; Wygowski J; Herold S; Mayer K; Vadász I; Besuch P; Mairbäurl H; Seeger W; Morty RE
    Respir Physiol Neurobiol; 2016 Jan; 220():54-61. PubMed ID: 26410457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FXYD proteins as regulators of the Na,K-ATPase in the kidney.
    Sweadner KJ; Arystarkhova E; Donnet C; Wetzel RK
    Ann N Y Acad Sci; 2003 Apr; 986():382-7. PubMed ID: 12763854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FXYD proteins: new tissue-specific regulators of the ubiquitous Na,K-ATPase.
    Crambert G; Geering K
    Sci STKE; 2003 Jan; 2003(166):RE1. PubMed ID: 12538882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholemman expression in extraglomerular mesangium and afferent arteriole of the juxtaglomerular apparatus.
    Wetzel RK; Sweadner KJ
    Am J Physiol Renal Physiol; 2003 Jul; 285(1):F121-9. PubMed ID: 12657562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Function of FXYD proteins, regulators of Na, K-ATPase.
    Geering K
    J Bioenerg Biomembr; 2005 Dec; 37(6):387-92. PubMed ID: 16691470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FXYD proteins: new regulators of Na-K-ATPase.
    Geering K
    Am J Physiol Renal Physiol; 2006 Feb; 290(2):F241-50. PubMed ID: 16403837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Splice variants of the gamma subunit (FXYD2) and their significance in regulation of the Na, K-ATPase in kidney.
    Arystarkhova E; Sweadner KJ
    J Bioenerg Biomembr; 2005 Dec; 37(6):381-6. PubMed ID: 16691469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term adaptation of renal cells to hypertonicity: role of MAP kinases and Na-K-ATPase.
    Capasso JM; Rivard CJ; Berl T
    Am J Physiol Renal Physiol; 2001 May; 280(5):F768-76. PubMed ID: 11292618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phospholemman (FXYD1) raises the affinity of the human α1β1 isoform of Na,K-ATPase for Na ions.
    Cirri E; Katz A; Mishra NK; Belogus T; Lifshitz Y; Garty H; Karlish SJ; Apell HJ
    Biochemistry; 2011 May; 50(18):3736-48. PubMed ID: 21449573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibre type-specific change in FXYD1 phosphorylation during acute intense exercise in humans.
    Thomassen M; Murphy RM; Bangsbo J
    J Physiol; 2013 Mar; 591(6):1523-33. PubMed ID: 23359667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.